These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Outcome with intracavitary high-dose-rate brachytherapy for primary vaginal cancer].
    Author: Kong W, Sun J.
    Journal: Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):94-6. PubMed ID: 11953073.
    Abstract:
    OBJECTIVE: To evaluate the efficacy of radiation therapy on primary vaginal cancer with high-dose-rate brachytherapy alone or in combination with external radiation. METHODS: Fifty one cases with primary vaginal cancer who were treated with high-dose-rate brachytherapy alone or in combination with the external radiation in Cancer Hospital, Chinese Academy of Medical Sciences from 1989 to 1999 were retrospectively studied, including stage I 10 cases, stage II 13 cases, stage III 23 cases and stage IV 5 cases. WD-HDR18 after-loading equipment was used in the brachytherapy and 6 or 8 MV linear accelerator was used in the external radiation. RESULTS: The overall 5-year survival rate with WD-HDR18 was 58.8%, with 80.0% for stage I, 76.9% for stage II, 65.2% for stage III, and 0.0% for stage IV. The comparison of treatments with WD-HDR18 and radium therapy showed the 5-year survival rates of the cases of each stage treated with WD-HDR18 were higher. CONCLUSION: Treatment results obtained with high-dose-rate brachytherapy are at least similar to traditional radium therapy for primary vaginal cancer.
    [Abstract] [Full Text] [Related] [New Search]